Loading...
XSHG600829
Market cap620mUSD
Dec 24, Last price  
7.88CNY
1D
-4.64%
1Q
45.17%
Jan 2017
-48.89%
Name

HPGC Renmintongtai Pharmaceutical Corp

Chart & Performance

D1W1MN
XSHG:600829 chart
P/E
15.64
P/S
0.44
EPS
0.50
Div Yield, %
0.54%
Shrs. gr., 5y
Rev. gr., 5y
8.05%
Revenues
10.39b
+7.77%
642,703,8771,768,996,2652,064,447,6972,268,208,0722,594,344,1272,638,253,1813,005,088,5953,605,738,9034,068,385,2923,177,004,8521,738,794,7258,909,315,3389,005,558,9848,008,880,9527,055,220,8848,353,884,4528,005,259,6889,315,235,6129,641,093,05510,389,980,123
Net income
292m
+10.47%
26,692,670145,126,720218,245,193268,085,492269,281,487278,786,373333,817,995398,595,494363,973,3076,462,05339,851,013138,916,248224,509,926254,196,034257,859,436267,334,545145,263,629277,296,173264,478,399292,161,807
CFO
333m
+8.35%
60,690,368313,036,770191,131,434191,103,6380447,824,979162,986,4910221,573,4020392,578,769333,987,60546,010,726139,074,593366,451,822000307,327,849332,985,565
Dividend
Jul 25, 20240.144 CNY/sh
Earnings
Jun 06, 2025

Profile

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
IPO date
Feb 24, 1994
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,389,980
7.77%
9,641,093
3.50%
9,315,236
16.36%
Cost of revenue
9,517,523
9,157,795
8,784,483
Unusual Expense (Income)
NOPBT
872,457
483,298
530,753
NOPBT Margin
8.40%
5.01%
5.70%
Operating Taxes
101,138
82,148
82,091
Tax Rate
11.59%
17.00%
15.47%
NOPAT
771,320
401,150
448,662
Net income
292,162
10.47%
264,478
-4.62%
277,296
90.89%
Dividends
(24,621)
(69,587)
Dividend yield
0.54%
1.79%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
962,080
1,229,886
1,267,984
Long-term debt
58,818
76,963
119,171
Deferred revenue
125,707
130,771
Other long-term liabilities
121,088
566
1,563
Net debt
(333,218)
84,839
543,524
Cash flow
Cash from operating activities
332,986
307,328
CAPEX
(23,484)
Cash from investing activities
(179,858)
Cash from financing activities
117,858
149,513
342,311
FCF
779,838
576,851
(79,123)
Balance
Cash
1,314,347
1,181,469
800,492
Long term investments
39,769
40,540
43,139
Excess cash
834,617
739,955
377,869
Stockholders' equity
2,751,375
2,463,698
2,200,251
Invested Capital
3,029,336
3,065,349
3,233,373
ROIC
25.31%
12.74%
15.09%
ROCE
22.56%
12.70%
14.70%
EV
Common stock shares outstanding
579,916
579,889
579,889
Price
7.82
22.57%
6.38
-5.06%
6.72
-9.43%
Market cap
4,534,945
22.58%
3,699,689
-5.06%
3,896,851
-9.43%
EV
4,201,684
3,784,528
4,440,376
EBITDA
934,917
547,290
591,191
EV/EBITDA
4.49
6.92
7.51
Interest
36,339
44,423
50,317
Interest/NOPBT
4.17%
9.19%
9.48%